Genesis Molecular AI Tech Stack

Foundation models for small-molecule drug discovery and optimization

Biotechnology Research Burlingame, California 51–200 employees Privately Held

Genesis Molecular AI operates a generative AI platform (GEMS) that integrates deep learning and physics simulation to accelerate small-molecule drug discovery. The tech stack—PyTorch, Ray, Kubernetes, RDKit, NVIDIA, cryo-EM—reflects a research-heavy organization optimizing for large-scale molecular modeling and GPU compute. Hiring velocity is accelerating with a senior/director-weighted mix (11 of 15 active roles) concentrated in research and engineering, pointing toward scaling both internal discovery programs and platform partnerships.

Tech Stack 21 technologies

Core StackAWS Python Terraform Kubernetes Ashby PyTorch GraphQL PyMOL GCP Bash Ray RDKit NVIDIA PyTorch Lightning PyTorch Geometric XLA Triton CUDA UniProt cryo-EM

What Genesis Molecular AI Is Building

◆Challenges

Novel targets with limited chemical precedents
Building ai and drug discovery ip portfolio
Managing patent renewals
Maintaining multi-cloud compute infrastructure
Scaling autoscaling compute clusters
Improving execution throughput
Model validation for drug discovery
Speed and accuracy of free energy calculations
Shortening turnaround time
Accelerating drug discovery

▲Active Projects

Development of project-specific computational approaches
Small molecule drug discovery programs
Drug discovery programs from hit id through candidate nomination
Ai/ml and drug discovery patent portfolio
University partnerships
Monitoring and deployment automation configuration
Orchestration scheduling framework
Generative foundation models at scale
Model validation and deployment for drug discovery
Free energy workflow integration into gems

Hiring Activity

Accelerating15 roles · 10 in 30d

Department

Research

Engineering

Executive

Legal

Product

Seniority

Senior

Director

Principal

Staff

Lead

Mid

Notable leadership hires: Chief of Staff

Company intelligence

Find more companies like Genesis Molecular AI by tech stack, pain points and active projects

Get started free

About Genesis Molecular AI

Genesis Molecular AI develops foundation models for molecular design, enabling chemists and drug discovery teams to generate and optimize drug candidates more efficiently. The platform, GEMS, combines generative diffusion models with free-energy simulation to cycle between AI prediction and wet-lab validation. The company operates a fully integrated laboratory in San Diego alongside computational teams in Burlingame and New York, and has signed AI platform collaborations with major pharma partners. Internal efforts focus on building a pipeline of proprietary drug programs targeting high-value and traditionally intractable molecular spaces.

HeadquartersBurlingame, California

Company Size51–200 employees

Hiring MarketsUnited States

Frequently Asked Questions

What is Genesis Molecular AI's core technology?

GEMS (Genesis Exploration of Molecular Space), a generative and predictive AI platform that integrates deep learning and physics to design and optimize small molecules for drug discovery. The platform includes a generative diffusion model called Pearl for structure prediction.

What tech stack does Genesis Molecular AI use?

PyTorch, PyTorch Lightning, PyTorch Geometric, Ray, Kubernetes, NVIDIA/CUDA, RDKit, AWS, GCP, Terraform, Triton, XLA, GraphQL, cryo-EM, and UniProt. The stack prioritizes GPU-accelerated deep learning and distributed compute for molecular simulations.

How this profile is built

Genesis Molecular AI's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.